QSITA-M 50/500MG SITAGLIPTIN 50MG+METFORMIN 500MG TABS 10’S

Quita-M 50/500mg is a combination medication that contains Sitagliptin 50mg and Metformin 500mg. It is primarily used for the management of type 2 diabetes mellitus in adults. Sitagliptin is a DPP-4 inhibitor that helps to increase insulin production and decrease glucose production in the liver, while Metformin is a biguanide that improves insulin sensitivity and reduces glucose absorption in the intestines. Together, they work synergistically to control blood sugar levels effectively.

In Kenya, Quita-M is commonly prescribed for patients who are unable to achieve adequate glycemic control with diet and exercise alone. It is particularly beneficial for overweight individuals with type 2 diabetes, as it aids in weight management. Additionally, Quita-M may help reduce the risk of diabetes-related complications. Patients should follow their healthcare provider’s instructions regarding dosage and lifestyle modifications for optimal results.